Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-17T06:56:05.383Z Has data issue: false hasContentIssue false

Thrombotic complications of treatment with antipsychotic drugs : risk factors

Published online by Cambridge University Press:  19 July 2023

W. Abid*
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
F. Chérif
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
N. Bouattour
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
R. Masmoudi
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
F. Guermazi
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
I. Feki
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
R. Sallemi
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
J. Masmoudi
Affiliation:
psychiatry “A” department, hedi Chaker University Hospital, sfax, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Antipsychotic agents (AP) are widely used drugs to treat psychotic symptoms. For decades, some studies suggested that there is a relationship between using (AP) and the risk of venous thromboembolism (VTE) and pulmonary embolism (PE). The causality of this association, its risk factors, and its implications for clinical practice have not been fully elucidated.

Objectives

We undertook a systematic literature review to evaluate the evidence for an association between antipsychotic medication and venous thromboembolic events (VTE) and to identify risk factors for these adverse effects.

Methods

To identify relevant studies, we searched the PubMed, Science Direct databases up using the following keywords « pulmonary embolism », « venous thromboembolism » « antipsychotics agents ». We also searched the reference lists relevant articles for related studies.

Results

Twelve articles are included in this analysis and indicate an elevated risk of VTE in antipsychotic drug users. The results showed that compared with non-users, current AP users have significantly increased risks of VTE. The risk of venous thrombosis in obese people was higher than that in overweight people, patients not less than 65 years old had an increased risk compared with younger patients . In addition, women taking antipsychotics had a higher risk of pulmonary embolism than men. The other factors that increased risk were use of second-generation antipsychotics and antipsychotic polytherapy. The highest risk was noted in the first 3 months of treatment. Data also suggested a dose-dependent increase in the risk of thrombotic complications. For individual drugs, increased risk of VTE and PE was observed in taking clozapine , haloperidol, risperidone and olanzapine. Clozapine was associated with the highest risk. However, careful interpretation is needed because of high heterogeneity among studies and scarce data.

Conclusions

The use of antipsychotics will increase the risk of venous thromboembolism and pulmonary embolism, which will be affected by AP and patient characteristics.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.